Tuesday, September 25, 2018

ASPIRIN NOT THE TOTAL MIRACLE DRUG I THOUGHT


Linda created this quilt for Margo and Phil Montague

It really seems that the grand debate about the health effects of aspirin will never end.  I have written about aspirin and cancer many times over the past few years: search of Myrl’sBlog turns up  15 references.  In general, aspirin seems to reduce the chance of developing cancers of many types. Now, however, comes some negative evidence.  A massive trial involving healthy elderly folks* turned up no overall longevity benefit from daily aspirin in small dosages/.  In fact, if anything, the non-aspirin control group had the better outcome.  There are lots of qualifiers, though, so read the NIH report.


However, as the focus of this blog is ovarian cancer, be sure to read this, too.


*Defined as over 70 for most of us, but over 65 for African Americans and Hispanics.

2 comments:

  1. More on this subject:

    https://www.clinicaladvisor.com/oncology/low-dose-aspirin-may-reduce-ovarian-cancer-risk/article/807123/

    ReplyDelete
  2. More dope on low-dose aspirin and its effect on ovarian cancer. I wish they would make up their mind.

    http://www.cancernetwork.com/ovarian-cancer/can-low-dose-aspirin-lower-ovarian-cancer-risk

    ReplyDelete